CD83 and cancer: A synthetic sulfolipid derived from Thalassiosira weissflogii CCMP1336 (Bacillariophyta), named SQDG18, was able to trigger an effective immune response against cancer cells to improve dendritic cell (DC) maturation and increase CD83-positive DC.